![]() Financial Daily from THE HINDU group of publications Saturday, Jan 22, 2005 |
|
|
|
|
|
Corporate
-
New Projects AstraZeneca begins work on R&D unit Our Bureau
Bangalore , Jan. 21 ASTRAZENECA has said it has started construction of a new process R&D facility in Bangalore. The new unit with an initial investment of $10 million is scheduled for completion by the middle of 2006, Ms Kumud Sampath, President, AZ R&D Bangalore, said. It will come up next to its year-old research facility and will be one of the company's four other process R&D facilities located worldwide. The PR&D facility covering 6,000 sq m on a 3.5-acre plot will house up to 50 more scientists and support staff. Dr Andy Jones, Director, Business Development, AstraZeneca plc, who was present at the ground-breaking ceremony, said recruitment had begun for adding a dozen scientists by 2005-end to an existing team of 25. Process R&D comes into the picture for further, larger scale research when a drug candidate has been identified. The Anglo-Swedish pharma major expects the facility to play a crucial role in taking the discovery phase of research to the commercial stage. In India, AZ's research unit is currently working on a new tuberculosis drug and may also take up research projects from the company's other global units, a spokesperson said.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|